PITTSBURGH, PA -- (Marketwired) -- 09/16/13 -- Neuro Kinetics, Inc., (NKI) (www.neuro-kinetics.com), manufacturers of neuro-otologic diagnostic devices used worldwide, is supporting the Vestibular Disorder Association's (VEDA's) Balance Awareness Week campaign to foster understanding of the symptoms and treatment for dizziness and other balance and equilibrium issues, the company said today.
VEDA's nationwide campaign of grassroots information outreach, education and advocacy programs starts today and runs through September 22, 2013. (More information: http://vestibular.org/baw)
"The goal of Balance Awareness Week is to help people recognize the symptoms of a vestibular disorder to promote rapid diagnosis and effective treatment," said Tony Staser, VEDA development director. "Ninety million Americans suffer from dizziness or imbalance during their lifetimes. The sooner people can get help, the sooner they are on a path to learning to cope with their illness."
Said Vince Kytka, NKI marketing director, "We are delighted to support VEDA is this important effort. We've been serving audiologists, otolaryngologists and other medical specialists for almost 30 years with tests and devices to diagnose various vestibular-related health problems. Yes, there has been tremendous progress in understanding and treating balance disorders and we're proud that our technology and precision equipment has helped the balance community improve early diagnosis. But there is still much to be accomplished."
NKI's devices and its proprietary I-Portal® platform technology precisely measure oculomotor (eye movement) functions, helping clinicians detect a broad range of vestibular and neurological pathologies.
VEDA is partnering with international advocacy groups to promote Balance Awareness Week globally, including the Ménière's Society UK (www.menieres.org.uk) and Ménière's Australia (www.menieres.org.au).
For more than 25 years, the Vestibular Disorders Association (VEDA) has provided objective information, advocacy and a caring support network to people with vestibular disorders and the health professionals who treat them. For more information, visit www.vestibular.org or call 800.837.8428.
Media contact: Tony Staser, Development Director @ 213.590.5360 or firstname.lastname@example.org.
Neuro Kinetics, Inc. (NKI) is the world leader in eye-tracking technology and non-invasive neuro-otologic diagnostic testing. Central to its product mix and technological advances is the premise that the eye is the portal to the brain. Research has shown the detection of abnormal eye reflexes can indicate the presence of more than 200 diseases and medical conditions.
NKI supplies comprehensive neuro-otologic diagnostic tools to audiologists, ENT's, neuro-otologists, neuro-ophthalmologists and neurologists around the globe. The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services.